Armata Pharmaceuticals (ARMP) Other Accumulated Expenses (2016 - 2026)
Quarterly results put Other Accumulated Expenses at $372000.0 for Q1 2026, up 10.39% from a year ago — trailing twelve months through Mar 2026 was $372000.0 (up 10.39% YoY), and the annual figure for FY2025 was $487000.0, down 7.94%.
Armata Pharmaceuticals has reported Other Accumulated Expenses over the past 6 years, most recently at $372000.0 for Q1 2026.
- Other Accumulated Expenses reached $372000.0 in Q1 2026 per ARMP's latest filing, down from $487000.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $529000.0 in Q4 2024 and bottomed at $124000.0 in Q2 2024.
- Median Other Accumulated Expenses over the past 4 years was $429500.0 (2025), compared with a mean of $384700.0.
- Peak annual rise in Other Accumulated Expenses hit 10.48% in 2025, while the deepest fall reached 7.94% in 2025.
- Over 4 years, Other Accumulated Expenses stood at $523000.0 in 2023, then rose by 1.15% to $529000.0 in 2024, then decreased by 7.94% to $487000.0 in 2025, then dropped by 23.61% to $372000.0 in 2026.
- Business Quant data shows Other Accumulated Expenses for ARMP at $372000.0 in Q1 2026, $487000.0 in Q4 2025, and $503000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 372,000.00 |
| Dec 31, 2025 | 487,000.00 |
| Sep 30, 2025 | 503,000.00 |
| Jun 30, 2025 | 137,000.00 |
| Mar 31, 2025 | 337,000.00 |
| Dec 31, 2024 | 529,000.00 |
| Sep 30, 2024 | 513,000.00 |
| Jun 30, 2024 | 124,000.00 |
| Mar 31, 2024 | 322,000.00 |
| Dec 31, 2023 | 523,000.00 |
| Sep 30, 2017 | 20,000.00 |
| Jun 30, 2017 | 408,000.00 |
| Mar 31, 2017 | 161,000.00 |
| Dec 31, 2016 | 185,000.00 |
| Sep 30, 2016 | 15,000.00 |
| Jun 30, 2016 | 15,000.00 |